BioAge Labs Inc.(BIOA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BIOA BioAge Labs Inc.

Closed Mourning Day 01-08 16:00:00 EST

5.09

-0.27

-5.04%

盘后5.34

+0.25+4.91%

19:53 EST

High5.35	Low4.79	Vol276.63K
Open5.29	D1 Closing5.36	Amplitude10.39%
Mkt Cap182.47M	Tradable Cap123.40M	Total Shares35.85M
T/O1.39M	T/O Rate1.14%	Tradable Shares24.24M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":5.09,"timestamp":1736370000000,"preClose":5.36,"halted":0,"volume":276629,"hourTrading":{"tag":"盘后","latestPrice":5.34,"preClose":5.09,"latestTime":"19:53 EST","volume":779,"amount":3986.3379,"timestamp":1736384020674},"delay":0,"floatShares":24243246,"shares":35848738,"eps":-33.128242,"marketStatus":"Closed Mourning Day","change":-0.27,"latestTime":"01-08 16:00:00 EST","open":5.29,"high":5.3468,"low":4.79,"amount":1391185.498514,"amplitude":0.103881,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-33.128242,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1736499600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1727323200000,"exchange":"NASDAQ","adjPreClose":5.36,"preHourTrading":{"tag":"盘前","latestPrice":5.25,"preClose":5.36,"latestTime":"08:42 EST","volume":66,"amount":357.749997,"timestamp":1736343725752},"postHourTrading":{"tag":"盘后","latestPrice":5.34,"preClose":5.09,"latestTime":"19:53 EST","volume":779,"amount":3986.3379,"timestamp":1736384020674},"volumeRatio":0.541512803697968},"requestUrl":"/m/hq/s/BIOA/tweets","defaultTab":"tweets","newsList":[{"id":"2501778024","title":"Levi & Korsinsky LLP Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2501778024","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501778024?lang=en_us&edition=fundamental","pubTime":"2025-01-08 01:20","pubTimestamp":1736270403,"startTime":"0","endTime":"0","summary":"THE LAWSUIT: This lawsuit is on behalf of all shareholders that purchased stock pursuant and/or traceable to BioAge’s registration statement for th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/levi-korsinsky-llp-notifies-shareholders-of-bioage-labs-inc-bioa-of-a-class-action-lawsuit-and-an-upcoming-deadline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/levi-korsinsky-llp-notifies-shareholders-of-bioage-labs-inc-bioa-of-a-class-action-lawsuit-and-an-upcoming-deadline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2500077974","title":"BioAge Labs, Inc. (BIOA) Loses -67.99% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner","url":"https://stock-news.laohu8.com/highlight/detail?id=2500077974","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500077974?lang=en_us&edition=fundamental","pubTime":"2025-01-02 22:35","pubTimestamp":1735828506,"startTime":"0","endTime":"0","summary":"BioAge Labs, Inc.  has been beaten down lately with too much selling pressure. While the stock has lost 68% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.We use Relative Strength Index , one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.The RSI reading of 27.57 for BIOA is an indication that the heavy selling could be in the process of exhausting itself, so th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioage-labs-inc-bioa-loses-143506211.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RSI","BIOA","BK4007","BK4150"],"gpt_icon":0},{"id":"2494386350","title":"BioAge Labs, Inc. (BIOA): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2494386350","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494386350?lang=en_us&edition=fundamental","pubTime":"2024-12-27 22:18","pubTimestamp":1735309111,"startTime":"0","endTime":"0","summary":"We came across abullish thesison BioAge Labs, Inc.  on Value Investing Subreddit Page by value1024. In this article, we will summarize the bulls’ thesis on BIOA. BioAge Labs, Inc. 's share was trading at $5.88 as of Dec 26th.BioAge Labs , a recent IPO in the biotech sector, has experienced significant volatility, dropping 75% from its $20 debut to around $6 last week. Despite the lack of revenue, the company maintains a $220M market cap and boasts over $9 per share in cash, providing runway until 2029. The sharp decline was driven by the termination of a clinical trial for its Azelaprag obesity drug, developed in collaboration with Eli Lilly, leading to investor concerns. However, the market seems to have misunderstood BIOA’s broader potential, as the company is far from a single-drug entity.BioAge Labs, Inc.  is not on our list of the31 Most Popular Stocks Among Hedge Funds. As per our database, 17 hedge fund portfolios held BIOA at the end of the third quarter which was 0 in the prev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioage-labs-inc-bioa-bull-141831408.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ",".IXIC","QLD","TSYW.SI","USJW.SI","QID","PSQ","NQmain","TQQQ","USAW.SI","NVIW.SI","MNQmain","BIOA","BK4007"],"gpt_icon":1},{"id":"2492061180","title":"BUZZ-U.S. STOCKS ON THE MOVE-American Battery Technology, Ollie's Bargain Outlet, BioAge Labs","url":"https://stock-news.laohu8.com/highlight/detail?id=2492061180","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492061180?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:49","pubTimestamp":1734536950,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-American Battery Technology, Ollie's Bargain Outlet, BioAge Labs Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7Th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nL4N3NJ152:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COMM","3NVD.UK","MYPS","ABAT","NVDD","HEI","NVDS","ANGI","SNVD.UK","NOTE","GIS","NVDY","NRGV","PKG","CGTX","OLLI","NOTV","CI","2NVD.UK","MACW.SI","NVD","WOR","NVDA","NVDS.UK","NVIW.SI","IAC","CRVS","NVDX","NVDU","GETY","XMTR","VNCE","PANW","MTCH","BIRK","GPCR","VKTX","RNAZ","YY","MRK","NVD2.UK","JBL","CVS","BIOA","NVD3.UK"],"gpt_icon":1},{"id":"2492187659","title":"BioAge Stock Advances 14% On Novartis Research Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2492187659","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492187659?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:21","pubTimestamp":1734535260,"startTime":"0","endTime":"0","summary":"BioAge Labs shares rose Wednesday after it said it entered into a research collaboration with the Swiss biopharmaceutical company Novartis, which could earn BioAge up to $550 million.Shares climbed 14% to $4.67, helping to regain some of the 76% loss BioAge experienced on Dec. 6 after it said it was discontinuing a phase-two trial for its obesity treatment.The Richmond, Calif.-based biopharmaceutical company will collaborate on a multi-year research project with Novartis investigating what drives aging-related diseases and the role of physical exercise in longevity. It combines BioAge's human longevity datasets with Novartis's specialty in exercise biology, BioAge said.Under the terms of the agreement, BioAge will receive upfront research funding and payments of up to $20 million, and up to $530 million in future research, development and commercial milestones. BioAge and Novartis both have the right to advance novel targets discovered during the collaboration.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","NVS","BK4585","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4007","BK4532","BK4578","IE00B4R5TH58.HKD","BK4588","BIOA","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0211331839.USD"],"gpt_icon":0},{"id":"2492182006","title":"BUZZ-BioAge Labs rises on Novartis collaboration for age-related disease drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2492182006","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492182006?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:19","pubTimestamp":1734535177,"startTime":"0","endTime":"0","summary":"BUZZ-BioAge Labs rises on Novartis collaboration for age-related disease drugs** Drug developer BioAge Labs' BIOA.O shares rise ~10% to $4.52** BIOA says it is collaborating with Swiss drugmaker Novartis NOVN.S to find new drug targets for age-related diseases** BIOA will receive $20 mln upfront and up to $530 mln in milestone payments** Including session's moves, stock down 80% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nL4N3NJ143:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2492603182","title":"BRIEF-Bioage Labs Announces Multi-Year Collaboration With Novartis To Discover Novel Targets For Therapies That Address Age-Related Diseases And Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2492603182","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492603182?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:02","pubTimestamp":1734534140,"startTime":"0","endTime":"0","summary":"Dec 18  - BIOAGE Labs Inc   :   * BIOAGE LABS ANNOUNCES MULTI-YEAR COLLABORATION WITH NOVARTIS TO DISCOVER NOVEL TARGETS FOR THERAPIES THAT ADDRESS AGE-RELATED DISEASES AND CONDITIONS   * NOVARTIS TO PAY UP TO $20M IN UPFRONT PAYMENTS AND RESEARCH FUNDING   * MAY RECEIVE UP TO $530M IN FUTURE MILESTONESSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360107671.USD","BK4008","BK4166","LU0106831901.USD","LU1791807156.HKD","BIOA","LU1861217088.USD","BK4585","UP","LU1861220207.SGD","LU1668664300.SGD","BK4588","DFS"],"gpt_icon":0},{"id":"2492665184","title":"BioAge Labs Says it is Partnering With Novartis to Identify Drug Targets to Treat Age-Related Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2492665184","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492665184?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:50","pubTimestamp":1734533427,"startTime":"0","endTime":"0","summary":"BioAge Labs  said Wednesday it is teaming up with Novartis  to identify drug targets to treat diseases related to aging.The multiyear research collaboration will use BioAge's human longevity data and platform and Novartis' expertise in physical exercise biology, BioAge said.The company said under the deal, it will get up to $20 million in upfront payments and research funding and may receive up to $530 million in future long-term research, development and commercial milestones.Each company has the right to advance novel targets discovered under the partnership and is eligible to get reciprocal success milestones and tiered royalties, BioAge said.Shares of BioAge jumped nearly 14% and Novartis fell 0.4% in recent Wednesday trading.Price: 4.70, Change: +0.60, Percent Change: +14.63","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","IE0009355771.USD","IE00B2B36J28.USD","BK4532","IE00B4R5TH58.HKD","LU0211331839.USD","IE00BFTCPJ56.SGD","BK4585","BIOA","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4578","IE0002141913.USD","NVS","BK4007"],"gpt_icon":0},{"id":"2492861551","title":"Bioage Labs Announces Multi-Year Collaboration With Novartis to Discover Novel Targets for Therapies That Address Age-Related Diseases and Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2492861551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492861551?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:00","pubTimestamp":1734530403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nTUA5T2DHV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2492618627","title":"Bioage Labs Inc - May Receive up to $530M in Future Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2492618627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492618627?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:00","pubTimestamp":1734530403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nTUA5T2DHV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2492186208","title":"Bioage Labs Inc - Novartis to Pay up to $20M in Upfront Payments and Research Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2492186208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492186208?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:00","pubTimestamp":1734530403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nTUA5T2DHV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2492186225","title":"BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2492186225","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492186225?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:00","pubTimestamp":1734530400,"startTime":"0","endTime":"0","summary":"Collaboration will leverage BioAge's differentiated human longevity data and platform and Novartis expertise in the biology of physical exercise to identify drug targets to treat diseases related to a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/18/2999089/0/en/BioAge-Labs-Announces-Multi-Year-Collaboration-with-Novartis-to-Discover-Novel-Targets-for-Therapies-that-Address-Age-Related-Diseases-and-Conditions.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360107671.USD","LU0106831901.USD","LU1861217088.USD","LU1861220207.SGD","BK4585","DFS","BK4588","BK4007","LU1668664300.SGD","BIOA","LU1791807156.HKD","BK4166"],"gpt_icon":0},{"id":"2490622218","title":"Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2490622218","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490622218?lang=en_us&edition=fundamental","pubTime":"2024-12-11 22:55","pubTimestamp":1733928900,"startTime":"0","endTime":"0","summary":"It was a busy week in the biotech sector with lots of data readouts. This apart, the key regulatory updates and pipeline news also continued to be in the spotlight.BioAge Labs’ BIOA shares plunged after the company announced that it would discontinue the ongoing mid-stage study of its investigational drug candidate, azelaprag.AMT-130 obtained the FDA’s Regenerative Medicine Advanced Therapy  designation to treat Huntington’s disease.The deal was made at an RMAT meeting with the regulatory body in November 2024. The FDA agreed that the reported data from the ongoing early to mid-stage studies of AMT-130 for Huntington’s disease, compared to a natural history external control, are sufficient to serve as the primary basis for a biologics license application  for accelerated approval.Initial results from randomized phase II CRDF-004 demonstrated an objective response rate  of 64% in the 30mg onvansertib dose arm, almost double the 33% ORR observed in the control arm .","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/b7YQi_HTDu1GkQZqPUqgyw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/b7YQi_HTDu1GkQZqPUqgyw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stock-roundup-bioa-down-145500028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INCY","BK4585","CRDF","BK4550","QURE","SOC","GSK.UK","BK4007","GSK","BK4532","LU1829250122.USD","BK4139","BK4588","BIOA","BK4213"],"gpt_icon":0},{"id":"2490099340","title":"Bioage Labs Inc : Morgan Stanley  Cuts to Underweight From Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2490099340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490099340?lang=en_us&edition=fundamental","pubTime":"2024-12-10 19:31","pubTimestamp":1733830265,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nAZN2SKZV0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2490408096","title":"Morgan Stanley Downgrades BioAge Labs to Underweight From Overweight, Slashes Price Target to $5 From $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2490408096","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490408096?lang=en_us&edition=fundamental","pubTime":"2024-12-10 19:22","pubTimestamp":1733829774,"startTime":"0","endTime":"0","summary":"Morgan Stanley Downgrades BioAge Labs to Underweight From Overweight, Slashes Price Target to $5 From $40","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA"],"gpt_icon":0},{"id":"2490098408","title":"BioAge Labs downgraded to Underweight from Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2490098408","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490098408?lang=en_us&edition=fundamental","pubTime":"2024-12-10 18:30","pubTimestamp":1733826635,"startTime":"0","endTime":"0","summary":"Morgan Stanley downgraded BioAge Labs (BIOA) to Underweight from Overweight with a price target of $5, down from $40. The company discontinued its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-downgraded-to-underweight-from-overweight-at-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-downgraded-to-underweight-from-overweight-at-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA"],"gpt_icon":0},{"id":"2490774850","title":"BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros, Seres Therapeutics, Enterprise Bancorp","url":"https://stock-news.laohu8.com/highlight/detail?id=2490774850","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490774850?lang=en_us&edition=fundamental","pubTime":"2024-12-09 23:51","pubTimestamp":1733759508,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros, Seres Therapeutics, Enterprise Bancorp Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning New","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nL4N3NA0Y1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACLX","DOW","RDW","SCCO","NKLA","CHTR","NVDU","DDOG","MCRB","IPG","BHP.AU","NEM","PTVE","RIO.UK","DOUG","BIOA","RVNC","EBTC","INDB","AEO","NVDY","WBD","VST","XIN","OCFT","RIO.AU","CMCSA","NVDA","06638","ALB","NVDD","RAD.AU","VSCO","SG","M","FCX","ANGO","ARE","TWI","ZEO","CHRW","LDTC","HSY"],"gpt_icon":1},{"id":"2490733707","title":"Bioage Labs Falls 76.9% After Jefferies Cuts PT on Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2490733707","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490733707?lang=en_us&edition=fundamental","pubTime":"2024-12-09 22:37","pubTimestamp":1733755043,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1EX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2490277757","title":"Traders Eye Key Inflation Report as US Equity Futures Waver Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2490277757","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490277757?lang=en_us&edition=fundamental","pubTime":"2024-12-09 21:47","pubTimestamp":1733752032,"startTime":"0","endTime":"0","summary":"US equity futures were flat before Monday's opening bell with investors' attention focused on the upcoming November consumer price index due for release later in the week.Dow Jones Industrial Average ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ce80b65d81efe1b77f4a858afaea82a8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4187","TQQQ","DXD","PSQ","BK4588","BK4585","DJX","SATL","NQmain","EQR","UDOW","SQQQ","BIOA","SDOW","DDM","BK4215","QLD","MNQmain",".IXIC","DOG",".SPX",".DJI","BK4007","QID"],"gpt_icon":1},{"id":"2490721960","title":"Bioage Labs Cut to Neutral From Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2490721960","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490721960?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:49","pubTimestamp":1733748540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 09, 2024 07:49 ET (12:49 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://bioagelabs.com","stockEarnings":[{"period":"1week","weight":-0.1209},{"period":"1month","weight":0.0946},{"period":"3month","weight":-0.7522},{"period":"6month","weight":-0.7172},{"period":"ytd","weight":-0.1209}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0251},{"period":"3month","weight":0.0232},{"period":"6month","weight":0.0527},{"period":"1year","weight":0.244},{"period":"ytd","weight":0.0058}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":" ","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.008123},{"month":2,"riseRate":0.4,"avgChangeRate":-0.16094},{"month":3,"riseRate":0.2,"avgChangeRate":-0.091972},{"month":4,"riseRate":0.4,"avgChangeRate":-0.044244},{"month":5,"riseRate":0,"avgChangeRate":-0.19738},{"month":6,"riseRate":0.25,"avgChangeRate":0.003055},{"month":7,"riseRate":0.4,"avgChangeRate":-0.005696},{"month":8,"riseRate":0.4,"avgChangeRate":-0.229124},{"month":9,"riseRate":0.6,"avgChangeRate":0.004924},{"month":10,"riseRate":0.8,"avgChangeRate":0.181962},{"month":11,"riseRate":0.6,"avgChangeRate":0.056827},{"month":12,"riseRate":0.2,"avgChangeRate":-0.087267}],"exchange":"NASDAQ","name":"BioAge Labs Inc.","nameEN":"BioAge Labs Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioAge Labs Inc.(BIOA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BioAge Labs Inc.(BIOA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BioAge Labs Inc.,BIOA,BioAge Labs Inc.股票,BioAge Labs Inc.股票老虎,BioAge Labs Inc.股票老虎国际,BioAge Labs Inc.行情,BioAge Labs Inc.股票行情,BioAge Labs Inc.股价,BioAge Labs Inc.股市,BioAge Labs Inc.股票价格,BioAge Labs Inc.股票交易,BioAge Labs Inc.股票购买,BioAge Labs Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioAge Labs Inc.(BIOA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BioAge Labs Inc.(BIOA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction